pembrolizumab
merck
['biomarker', 'keynote-604', 'sclc']
6/ this exploratory analysis of biomarker subgroups in keynote-604 highlights the need for more research to better identify predictive biomarkers for immunotherapy. join us in advancing the fight against sclc. #asco23 
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer